- Tytuł:
- Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO – PRODIGE 82)
- Autorzy:
- Źródło:
- BMC Cancer. 23(1)
Czasopismo naukowe